Effect of midbrain raphe lesion and of 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats.
D000700:Analgesics / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles; D003521:Cyclopropanes / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis; D005260:Female; D000441:Hexanols / Q000494:pharmacology; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D007267:Injections; D008636:Mesencephalon / Q000502:physiology*; D009019:Morphinans / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D012701:Serotonin / Q000032:analysis; D013050:Spectrometry, Fluorescence; D013623:Tail / Q000187:drug effects
D000700:Analgesics; D003521:Cyclopropanes; D000441:Hexanols; D006892:Hydroxydopamines; D009019:Morphinans; D009292:Narcotic Antagonists; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine